News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Paolo Tarantino: The SERENA6 phase 3 trial is positive
Paolo Tarantino/X
Feb 28, 2025, 08:09

Paolo Tarantino: The SERENA6 phase 3 trial is positive

Paolo Tarantino,  Advanced Research Fellow at Dana-Farber Cancer Institute, shared a post on X:

“The SERENA6 phase 3 trial is positive: a switch to camizestrant + CDK4/6i (vs continuation of AI + CDK4/6i) upon emergence of ESR1 mutations led to a significant improvement in PFS.

PFS2 and OS, which will be key to interpret the results, remain immature.”

Paolo Tarantino: The SERENA6 phase 3 trial is positive

AI camizestrant cancer CDK4/6i Dana-Farber Cancer Institute ESR1 fight against cancer Global fight against cancer OncoDaily Oncology Paolo Tarantino PFS SERENA6
Special Coverage
Insight
Apr 21, 2025, 19:55
CXCL8, Neutrophils, and Tumor Immunity: Insights by James P. Crowley
Blog
Apr 21, 2025, 19:34
Karin Manchester: When I was told I had leukaemia, I never thought I would still be here 20 years later - ICR
Blog
Apr 21, 2025, 19:12
European School of Oncology Shares New Oncopedia Module on Breast Cancer
Blog
Apr 21, 2025, 18:55
Julie Ince-Demetriou: National Breast Cancer Foundation is hiring science communications specialist
Blog
Apr 21, 2025, 18:19
Lung Cancer Consensus Statement is now officially endorsed by ICC
Blog
Apr 21, 2025, 18:00
Ajlan Al Zaki’s Inspiring Medical Journey Recognized by Alexis Geppner
Insight
Apr 21, 2025, 17:40
Nazik Hammad Publishes Framework on Women, Power, and Cancer in The Lancet
Blog
Apr 21, 2025, 17:35
Stephen Liu: Georgetown Cancer Institute is looking for a sarcoma specialist
Blog
Apr 21, 2025, 17:29
Yan Leyfman: How many future cancers could be linked to CT scans in the U.S.
Blog
Apr 21, 2025, 17:21
Richard Scolyer: Proud of my contributions to the WHO over more than 20 years
Blog
Apr 21, 2025, 17:07
Nehemias Guevara-Rodriguez supports Dr. Narjust Florez’s candidacy for the IASLC Board of Directors
Blog
Apr 21, 2025, 17:04
Taro Yamanaka: DESTINY-Breast09 T-DXd + pertuzumab significantly improved PFS vs. THP in 1L setting